ABM often fails because it's treated as a siloed marketing initiative. To be effective, it must be an "Account-Based Experience" (ABX) where marketing, sales, and operations are fully integrated to create a seamless, unified journey for the entire target account.

Many brands practice multi-channel marketing, addressing customers on various platforms, but fail at true omnichannel. The key distinction is context continuity, where each new interaction is informed by the previous one. Most brands still struggle with this, but combining predictive analytics with Gen AI is making seamless, contextual omnichannel experiences a reality.

Go-to-market success isn't just about high-performing marketing, sales, and CS teams. The true differentiator is the 'connective tissue'—shared ICP definitions, terminology, and smooth handoffs. This alignment across functions, where one team's actions directly impact the next, is where most organizations break down.

Structuring marketing teams in channel-specific silos forces them to optimize for internal structures rather than the fluid, non-linear path customers actually take. This creates a fragmented view of performance, leading to wasted effort and missed opportunities.

The industry's historical success with large sales forces repeating messages to doctors created a deep-seated cultural mindset. This legacy of "pushing" information is a primary barrier to adopting a more human-centric, digitally native approach based on listening and responding to customer needs.

The pandemic acted as an unavoidable wake-up call, compelling the slow-moving pharmaceutical industry to rapidly adopt digital engagement models and embrace a more agile, customer-focused commercial approach, achieving in one year what would have taken ten.

The most common human failure in marketing orchestration is attempting to build a complex, multi-channel system from day one. Successful teams start simple: they nail the ICP and creative for a few channels, prove the value with clear measurement, and then use those wins to get buy-in from other teams and break down silos.

When patient engagement is owned by a single department, it's often treated as optional. To make it a core business driver, responsibility must be shared across R&D, medical, regulatory, and commercial teams. This requires a structural and cultural shift to become truly transformational for the organization.

Despite fewer resources, smaller enterprises often succeed with ABM where large tech fails. Their success stems from faster alignment between sales and marketing, fewer layers of bureaucracy, and the agility to create and execute campaigns quickly without being bogged down by silos.